C
CNS Pharmaceuticals, Inc. (CNSP)
NCM – Real vaqt narxi. Valyuta: USD
2.44
-0.13 (-4.87%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
2.45
+0.01 (0.41%)
Bozordan keyin: Mar 27, 2026, 5:09 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
2.44
-0.13 (-4.87%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
2.45
+0.01 (0.41%)
Bozordan keyin: Mar 27, 2026, 5:09 PM EDT
CNS Pharmaceuticals, Inc., klinik farmatsevtik kompaniya, miya va markaziy nerv sistemasining (MNS) o'smalarini davolash uchun saratonga qarshi dori nomzodlarini ishlab chiqadi. Kompaniyaning dori nomzodlari orasida TPI 287 va Berubicin mavjud bo'lib, ular glioblastoma va boshqa MNS xavfli o'smalarini davolash uchun 2-bosqich klinik sinovlarida. Kompaniyaning Cortice Biosciences, Inc. bilan litsenziya shartnomasi mavjud. Kompaniya 2017 yilda tashkil etilgan va Xyuston, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Lynne Kelley F.A.C.S., M.D. | Chief Medical Officer |
| Mr. Christopher S. Downs CPA, CTP, FP&A | Senior Vice President of Finance |
| Mr. Dylan Wenke M.B.A. | Chief Business Officer |
| Mr. Eric Faulkner M.B.A., M.Sc. | Chief Technology Officer |
| Mr. Rami Levin M.B.A. | President, CEO & Director |
| Mr. Steve O'Loughlin | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-11 | 8-K | cns_8k.htm |
| 2026-03-02 | 8-K | cns_8k.htm |
| 2025-12-17 | 8-K | cns_8k.htm |
| 2025-11-21 | 8-K | cns_8k.htm |
| 2025-11-14 | 10-Q | cns_i10q-093025.htm |
| 2025-11-12 | DEFA14A | cns_defa14a.htm |
| 2025-10-28 | ARS | cns_ars-123124.pdf |
| 2025-10-24 | DEF 14A | cns_def14a.htm |
| 2025-10-10 | PRE 14A | cns_pre14a.htm |
| 2025-08-14 | 10-Q | cns_i10q-063025.htm |